The US Food and Drug Administration (@US_FDA) has declined to approve antidepressant fluvoxamine as a treatment for #COVID19 as data is insufficient to conclude its effectiveness against the virus. pic.twitter.com/Rm6Wwk5sBE— IANS (@ians_india) May 17, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


